South Dakota Investment Council’s Supernus Pharmaceuticals SUPN Stock Holding History

South Dakota Investment Council’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,991	Closed	-$92K	–	589
2021 Q2	$92K	Sell	2,991 -98,420	-97%	-$3.02M	﹤0.01%	571
2021 Q1	$2.65M	Buy	101,411 +334	+0.3%	+$9.34K	0.04%	312
2020 Q4	$2.54M	Hold	101,077	–	–	0.05%	304
2020 Q3	$2.11M	Sell	101,077 -11,420	-10%	-$259K	0.05%	300
2020 Q2	$2.67M	Hold	112,497	–	–	0.06%	243
2020 Q1	$2.02M	Sell	112,497 -103	-0.1%	-$2.16K	0.05%	258
2019 Q4	$2.67M	Sell	112,600 -1,700	-1%	-$41.3K	0.06%	273
2019 Q3	$3.14M	Buy	114,300 +37,800	+49%	+$1.12M	0.06%	271
2019 Q2	$2.53M	Buy	76,500 +10,600	+16%	+$363K	0.05%	266
2019 Q1	$2.31M	Hold	65,900	–	–	0.05%	289
2018 Q4	$2.19M	Hold	65,900	–	–	0.06%	263
2018 Q3	$3.32M	Buy	65,900 +300	+0.5%	+$14.8K	0.07%	218
2018 Q2	$3.93M	Hold	65,600	–	–	0.09%	189
2018 Q1	$3M	Buy	+65,600	New	+$2.74M	0.07%	217

Other funds holding SUPN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

South Dakota Investment Council's SUPN Position: Q3 2021 in Review

South Dakota Investment Council sold out of Supernus Pharmaceuticals (SUPN) in Q3 2021, closing a stake of 2,991 shares — an estimated $92K sold.

South Dakota Investment Council first reported a position in SUPN in Q1 2018 and held it in 14 quarters. The position peaked at $3.93M in Q2 2018. 223 funds tracked by Wall St. Rank hold SUPN as of Q3 2021.

South Dakota Investment Council reported no remaining Supernus Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
South Dakota Investment Council sold 2,991 Supernus Pharmaceuticals shares in Q3 2021, an estimated $92K.
South Dakota Investment Council first reported a position in Supernus Pharmaceuticals in Q1 2018 and held it in 14 quarters.
South Dakota Investment Council's Supernus Pharmaceuticals position peaked at $3.93M in Q2 2018.
223 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2021.

Based on South Dakota Investment Council's 13F filing for Q3 2021, filed 9 Nov 2021.